M. Bansal

Infectious Diseases · with Bhatia · 2009–2020

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Bansal trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. G. Oudit

Papers from M. Bansal's perspective

Ordered by how strongly the researchers M. Bansal trusts endorse each paper. Same corpus, a different order for every researcher.

  1. [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. (Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi)
  2. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study (The Lancet)
  3. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
  4. Laboratory abnormalities in patients with COVID-2019 infection (Clinical Chemistry and Laboratory Medicine)
  5. Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2 (Circulation)
  6. SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS (European Journal of Clinical Investigation)
  7. Coronaviruses and the cardiovascular system: acute and long-term implications (European Heart Journal)
  8. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China (Clinical Research in Cardiology)
  9. Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State (Journal of Emergency Medicine)
  10. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study (The Lancet)

Their papers